As of May 23, 2025, PetIQ Inc (PETQ) reports a Gross Margin of 22.94%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of PetIQ Inc's Gross Margin
Over recent years, PetIQ Inc's Gross Margin has shown a moderate pattern. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2023-12-31 | 22.94% |
| 2022-12-31 | 22.75% |
| 2021-12-31 | 19.99% |
| 2020-12-31 | 17.33% |
| 2019-12-31 | 15.14% |
This slight upward trend highlights how PetIQ Inc manages its operational efficiency and pricing power over time.
Comparing PetIQ Inc's Gross Margin to Peers
To better understand PetIQ Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| PetIQ Inc (PETQ) | 22.94% |
| SurgLine International Inc (SGLN) | 7775.20% |
| Biora Therapeutics Inc (PROG) | 100.00% |
| HLS Therapeutics Inc (HLS.TO) | 84.11% |
| Castle Biosciences Inc (CSTL) | 81.87% |
| Medical Marijuana Inc (MJNA) | 76.40% |
Compared to its competitors, PetIQ Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.